Atypical Antipsychotics Linked to Lower Odds of COVID

Atypical Antipsychotics Linked to Decrease Odds of COVID

Second-generation antipsychotics appeared to curb COVID-19 infection in those with serious mental illness, a retrospective study showed. Looking at adults hospitalized long-term in the New York psychiatric system in 2020, those taking any agent in the class of second-generation antipsychotic medications, also known as atypical antipsychotics, had a 38% lower chance of infection (OR 0.62,…